ask="1.05"
ask_size="2000"
average_daily_volume="109438"
bid="0.99"
bid_size="5000"
book_value="0.53"
change="+0.04"
change_from_200_day_moving_average="-0.43"
change_from_50_day_moving_average="-0.21"
change_from_52_week_high="-6.98"
change_From_52_week_low="0.07"
change_in_percent="+4.28%"
close="0.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.01"
ebitda="-15.83M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.99"
high_52_weeks="7.95"
last_trade_date="3/9/2017"
last_trade_price="0.97"
last_trade_size="200"
last_trade_time="3:59pm"
low="0.90"
low_52_weeks="0.90"
market_capitalization="15.90M"
moving_average_200_day="1.40"
moving_average_50_day="1.18"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.00"
open="0.92"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-30.62%"
percent_change_from_50_day_moving_average="-17.81%"
percent_change_from_52_week_high="-87.80%"
percent_change_from_52_week_low="+7.78%"
previous_close="0.93"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.75"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.23"
stock_exchange="NGM"
symbol="ORPN"
volume="761492"
weeks_range_52="0.90 - 7.95"
